Not Yet Recruiting
A Study to Evaluate the Safety, Tolerability and Drug Levels of BMS-986446 in Healthy Participants and Healthy Participants of Japanese Ethnicity - CN008-0016
Actualizada: 10 octubre, 2023 | ClinicalTrials.gov
Fase
Géneros
Rango de edad
Ubicación (es)
Not Yet Recruiting
Inclusion Criteria: - Participant must be of Japanese ethnicity (both biological parents are ethnically Japanese) for Part 1 and Part 2, Panel 2. No limitations on ethnicity apply to Part 2, Panel 1 - Participant is healthy, without any significant abnormalities in medical history, physical examination, ECGs, or clinical laboratory assessments determinations, as assessed by the investigator - Body mass index (BMI) of at least 18 kg/m^2 but no more than 32 kg/m^2 at screening - Body weight between 45 kg and 110 kg Exclusion Criteria: - Any clinically significant deviation from normal, as judged by the investigator - Any major surgery within 90 days of study drug administration - Participation in another interventional clinical trial concurrent with this study Note: Other protocol-defined inclusion/exclusion criteria apply
Recomendamos encarecidamente que se comunique con BMS para informar los efectos secundarios (eventos adversos)
Los efectos secundarios (eventos adversos) y otros eventos reportables se definen aquí
Informe de efectos secundarios (eventos adversos) o quejas sobre la calidad del producto: información médica
